We have investigated the effect of measurement errors on cardiac output, calculated via three different Fick methods. In method 1, the classic O2 Fick equation is expressed in terms of oxygen uptake (VO2), arterial pulse (SaO2) and venous oximetry (SVO2) saturations. The second method, a modified CO2 Fick method, is obtained by replacing VO2 in method 1 with carbon dioxide production (VCO2) divided by the respiratory quotient. In method 3, cardiac output is expressed as VCO2 divided by the product of the SaO2-SVO2 difference and a constant. This constant is determined from initial measurements of VCO2, SaO2, SVO2, and thermodilution cardiac output (Qth). This determination of the constant results in equality of the initial cardiac output of method 3 with the simultaneously determined Qth and, therefore, is similar to performing an autocalibration. For each of the three preceding Fick methods, we derive general expressions that explicitly show how measurement errors (random and systematic) in the Fick variables (VO2, VCO2, SaO2, and SVO2) propagate into errors in calculated cardiac output. The errors in theoretically calculated cardiac output decrease as the SaO2-SVO2 difference increases, except for the systematic error in method 3. The systematic error of method 3 is constant and depends only upon the accuracy of the initial Qth. Analytic expressions for the sensitivity of calculated cardiac output to errors in individual Fick variables are also obtained. Using estimates from the literature for typical systematic and random measurement errors in the Fick variables, the resultant errors in cardiac output are numerically calculated. The effect of random measurement errors on errors in calculated cardiac output was comparable among the three methods. However, the systematic error was least with method 3. Total errors (random and systematic) were comparable among the three methods. Using these numerical measurement errors, we conclude that continuous cardiac output may be calculated with comparable accuracy with each of these methods.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/BF01617731 | DOI Listing |
Cardiol Rev
January 2025
Departments of Cardiology and Medicine, New York Medical College and Westchester Medical Center, Valhalla, NY.
Right ventricular myocardial infarction (RVMI) is a significant and distinct form of acute myocardial infarction associated with considerable morbidity and mortality. It occurs most commonly due to proximal right coronary artery obstruction, often in conjunction with inferior myocardial infarction. RVMI poses unique diagnostic and therapeutic challenges due to the anatomical and functional differences between the right and left ventricles.
View Article and Find Full Text PDFCurr Rev Clin Exp Pharmacol
January 2025
Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Introduction: In this study, a meta-analysis was conducted to investigate the therapeutic effect of Dapagliflozin (DAPA) on animals suffering from myocardial ischemia reperfusion compared to the group that did not receive treatment.
Methods: According to the inclusion and exclusion criteria two researchers performed the primary and secondary screening based on the title abstract and full text. After data extraction, meta-analysis was performed using STATA software.
Minerva Cardiol Angiol
January 2025
Department of Anatomy and Embryology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.
In clinical practice, ventricular ejection fraction (EF) and global longitudinal strain (GLS) are the most often used parameters for evaluating left ventricular systolic function, despite the impact that variable loading conditions have. Alternatively, the myocardial efficiency (ME) of the heart, encompassing cardiac energy formation and dissipation, along with myocardial oxygen consumption (MVO
J Cardiothorac Vasc Anesth
January 2025
Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA.
Vasoplegia is a pathophysiologic state of hypotension in the setting of normal or high cardiac output and low systemic vascular resistance despite euvolemia and high-dose vasoconstrictors. Vasoplegia in heart, lung, or liver transplantation is of particular interest because it is common (approximately 29%, 28%, and 11%, respectively), is associated with adverse outcomes, and because the agents used to treat vasoplegia can affect immunosuppressive and other drug metabolism. This narrative review discusses the pathophysiology, risk factors, and treatment of vasoplegia in patients undergoing heart, lung, and liver transplantation.
View Article and Find Full Text PDFBMJ Open
January 2025
Department of Cardiovascular Sciences, University of Leicester and the National Institute for Health Research Leicester Biomedical Research Centre, Glenfield Hospital, Leicester LE3 9QP, UK
Introduction: Heart failure with preserved ejection fraction (HFpEF) is characterised by severe exercise intolerance, particularly in those living with obesity. Low-energy meal-replacement plans (MRPs) have shown significant weight loss and potential cardiac remodelling benefits. This pragmatic randomised trial aims to evaluate the efficacy of MRP-directed weight loss on exercise intolerance, symptoms, quality of life and cardiovascular remodelling in a multiethnic cohort with obesity and HFpEF.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!